Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.

Related Posts

Why this veteran strategist is dropping his preference for tech stocks after 15 years

Why this veteran strategist is dropping his preference ...

Why IBM plans to buy Confluent in its biggest deal since 2019

Why IBM plans to buy Confluent in its biggest deal sinc...

Young men aren’t investing in a 401(k) for retirement — they’re banking on bitcoin

Young men aren’t investing in a 401(k) for retirement —...

Douglas Dynamics stock price target maintained at $39 by DA Davidson

Douglas Dynamics stock price target maintained at $39 b...

My mother-in-law, 81, is guilting us into paying for her ‘bucket list’ trip to Italy. Do we say no?

My mother-in-law, 81, is guilting us into paying for he...

Truist Securities lowers SL Green Realty stock price target on 2026 outlook

Truist Securities lowers SL Green Realty stock price ta...